Trial NCT02561832

View at ClinicalTrials.gov 
Org. Study IDs: D081EC00001

Last trial update was posted on 2019-02-20

MeSH Interventions

Carboplatin Cyclophosphamide Olaparib

MeSH Conditions

Breast Neoplasms

Other Conditions

Breast Cancer

Stopping Reasons

This decision was based upon strategic considerations impacting the clinical development of olaparib in this indication.

Limitations And Caveats

Early termination leading to a small number of subjects analyzed (N=15).

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID